ScandicNeuro Corp

Exciting News! - ScandicNeuro Exciting News! Exciting News! April 21, 2026 s11admin Exciting news! Dr. Dobson felt both honored and humbled to be named an inaugural Fellow of the International Neuropsychological Society (INS) at the 2026 INS Annual Conference in Philadelphia, in the company of many distinguished and highly respe...

In what ways can neuropsychology add value to global clinical trial research?

In what ways can neuropsychology add value to global clinical trial research? - ScandicNeuro In what ways can neuropsychology add value to global clinical trial research? In what ways can neuropsychology add value to global clinical trial research? March 4, 2026 s11admin In what ways can neuropsychology add value to global clinical trial research? Neuropsychology supports global clinical tr...

Happy New Year!
We wish you prosperity and success in the New Year and look forward to an exciting and inspiring 2026!

A study from the University of Pittsburgh and UPMC Children’s Hospital has identified an epigenetic signature to help track and improve recovery after pediatric traumatic brain injury (TBI). Published in the Journal of Neurotrauma, it’s the first to reveal DNA changes that distinguish children with complicated mild to severe TBI from those with non-neurological injuries.
https://www.health.pitt.edu/news/pitt-study-finds-signature-pediatric-brain-injury

Recent research has revealed that long-term use of common over-the-counter pain medications, such as aspirin and ibuprofen, may be associated with a 12% reduction in dementia risk. This finding comes from a study by Erasmus MC University Medical Center Rotterdam researchers, who tracked 11,745 adults over an average of 14.5 years.

The study found that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) was linked to a decreased risk. In contrast, short-term (less than one month) and intermediate-term (one to 24 months) use showed a slight increase in risk compared to the general population. Cumulative doses without consistent use did not appear beneficial.

Scientists hypothesize that long-term use of these anti-inflammatories may help clear out the accumulation of plaques associated with dementia and Alzheimer's disease. However, it's important to note that long-term use of NSAIDs comes with potential risks, including gastrointestinal bleeding and cardiovascular issues.

Long‐Term Exposure to Non‐Steroidal Anti‐Inflammatory Medication in Relation to Dementia Risk Background Non-steroidal anti-inflammatory (NSAID) medication could reduce dementia risk due to anti-inflammatory and possibly amyloid-lowering properties. However, the results of observational stud...